The study investigates the potential of virus-like particles derived from plant viruses and bacteriophages to deliver nucleic acid therapeutics effectively.
Evaluated virus-like particle designs based on plant viruses and bacteriophages.
Assessed their capabilities as delivery systems for nucleic acid therapeutics.
Analyzed the effectiveness in targeted delivery strategies.
Virus-like particles showed promise in enhancing the delivery efficiency of nucleic acid therapeutics.
Demonstrated compatibility with various nucleic acid types for therapeutic use.
Abstract
Virus-like particles from plant viruses and bacteriophages are emerging platform technologies for the delivery of nucleic acid therapeutics.